Skip to main content
. 2015 Jun 11;34(2):595–602. doi: 10.3892/or.2015.4051

Figure 1.

Figure 1

Expression of miR-153 in pancreatic ductal adenocarcinoma (PDAC) cases and cells. (A) Comparing differences in the expression levels of miR-153 between PDAC cell lines with different metastatic potentials and the normal human pancreatic duct epithelial cell line HPDE6-C7. n, three independent experiments, *P<0.05. (B) The expression of miR-153 in PDAC tissues was significantly lower than that in normal pancreas tissues. *P<0.05.